kezar life sciences share price

Wells Fargo Company upped their target price on shares of Kezar Life Sciences from 1300 to 1700 and gave the stock an overweight rating in. AFTER HOURS 408 PM EDT 072822.

Kezar Life Sciences Inc Kzr Stock Price News Info The Motley Fool

Aug 1 52000 PM GMT-4 USD NASDAQ Disclaimer.

. Put funds into your brokerage account. Research Kezar Life Sciences stock. The Companys product portfolio includes KZR-616 and KZR-261.

KZR points to an 818 upside in the stock. Keep an eye on your KZR investment. Summary of all time highs changes and price drops for Kezar Life Sciences.

1 day agoWells Fargo Company raised their price objective on shares of Kezar Life Sciences from 1300 to 1700 and gave the stock an overweight rating in. Is a clinical-stage biopharmaceutical company that is focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. See the latest Kezar Life Sciences Inc stock price NASDAQKZR related news valuation dividends and more to help you make your investing decisions.

To reiterate here are the 6 steps you need to take to buy Kezar Life Sciences stock right now. NASDAQ USD Post-Market. 983 -061 Kezar Life Sciences Appoints Nick Mordwinkin as Chief Business Officer and Reports Updated Cash Position Business Wire - Mon Jul 11 330PM CDT.

Kezar Life Sciences KZR stock price revenue and financials. KZR Kezar Life Sciences IncStock Price Overview. Δ 5 Yr.

Decide where to buy Kezar Life Sciences stock. Kezar Life Sciences Inc. Kezar Life Sciences market cap is 441 m.

1 day agoKezar Life Sciences Inc Nasdaq. According to the issued ratings of 2 analysts in the last year the consensus rating for Kezar Life Sciences stock is Buy based on the current 2 buy ratings for KZR. 17 hours agoIn addition the Compensation Committee of the companys Board of Directors granted one additional employee a nonqualified stock option to purchase 60000 shares of its common stock with an exercise price of 935 per share which is equal to the closing price of Kezars common stock on August 1 2022.

977 -005 -051 400 PM 072922. Nasdaq UNOFFICIAL CLOSE 400 PM EDT 072822. Δ 1 Yr.

Open a brokerage account. The KZR share price rallied over 100 as investors sought to. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders today announced that in connection with the previously announced appointment of Nick Mordwinkin PharmD PhD as the Companys Chief Business Officer the Compensation.

Get the latest info and learn more about Kezar Life Sciences IncKZR. SOUTH SAN FRANCISCO Calif August 03 2022 -- BUSINESS WIRE -- Kezar Life Sciences Inc Nasdaq. View Kezar Life Sciences Inc KZR investment stock information.

Make your KZR buy order. KZR a clinical-stage biotechnology company discovering and developing breakthrough. The mean of analysts price targets for Kezar Life Sciences Inc.

Get the latest Kezar Life Sciences Inc KZR detailed stock quotes. The average twelve-month price prediction for Kezar Life Sciences is 1967 with a high price target of 2200 and a low price target of 1700. Kezar Life Sciences Inc.

While this highly sought-after metric has not proven reasonably effective strong agreement. Kezar Life Sciences Inc. Wed like to share more about how we.

KZR 989 019 196 Post-Market 037 374 1842. Learn more on KZRs analyst rating. Kezar Life Sciences offers medium-term alpha opportunity with clinical trial momentum now inflecting positively on KZRs chart.

Kezar Life Sciences Inc.

O3zdwze Zr15m